can glp 1 help with alcohol addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Frontiers | The therapeutic potential

It has the potential to have both effects depending on how much your body produces

BPC 157 reduces various arrhythmias (i.e., potassium overdose-induced hyperkalemia (Barisic et al., 2013), digitalis (Balenovic et al., 2009), neuroleptics (i.e., prolonged QTc-intervals that may also be centrally related) (Strinic et al., 2017), bupivacaine (Zivanovic-Posilovic et al., 2016), lidocaine (Lozic et al., 2020), and succinylcholine (Stambolija et al., 2016))

This exact scenario accounts for a large portion of the adverse events the FDA has documented

Some medications are approved for diabetes , some for obesity , and some for both